Login / Signup
Response to: 'Risk of severe infection following rituximab and the efficacy of antimicrobial prophylaxis' by Wallace et al.
Andreas Kronbichler
Julia Kerschbaum
Published in:
Annals of the rheumatic diseases (2019)
Keyphrases
</>
diffuse large b cell lymphoma
staphylococcus aureus
early onset
hodgkin lymphoma
drug induced